This finding shows the potential of LEPR as a novel therapeutic target for hepatocellular carcinoma, while the LEPR-ANXA7 complex may serve as a potential target for tumour growth and metastasis prevention, which influences the occurrence and development of liver cancer. This evidence concerns the gene ANXA7 and hepatocellular carcinoma.